James Harnett

3PUBLICATIONS
11CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 20, 2026
Comparative economic analysis of B-cell maturation antigen-targeted bispecific antibodies in triple-class exposed relapsed/refractory multiple myeloma: linvoseltamab versus teclistamab and elranatamab.

|Feb 27, 2025
Patient preferences for triple-class-exposed relapsed or refractory multiple myeloma treatment: a discrete-choice study.

Sikander Ailawadhi, Timothy J Inocencio, Carol Mansfield

|Oct 09, 2020
Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis.

Stanley B Cohen, Jeffrey D Greenberg, James Harnett

Pageof 1

Frequent Collaborators

2 joint publications

Timothy J Inocencio

1 joint publications

Carol Mansfield

1 joint publications

Phani Chintakayala

1 joint publications

Glenn S Kroog